Medications for Glaucoma
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Glaucoma.
Found 16 Approved Drugs for Glaucoma
Timolol
Brand Names
Betimol, Timoptic-XE, Timoptic, Timolol GFS, Istalol
Timolol
Brand Names
Betimol, Timoptic-XE, Timoptic, Timolol GFS, Istalol
Form: Tablet, Solution
Method of administration: Oral, Ophthalmic
FDA approval date: November 05, 1986
Classification: beta-Adrenergic Blocker
Timolol maleate ophthalmic gel forming solution is indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Timolol maleate is a beta adrenergic blocker indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Latanoprost
Brand Names
Xelpros, Iyuzeh, Xalatan
Latanoprost
Brand Names
Xelpros, Iyuzeh, Xalatan
Form: Solution
Method of administration: Ophthalmic, Topical
FDA approval date: March 20, 1995
Classification: Prostaglandin Analog
XELPROS (latanoprost ophthalmic emulsion)
Hydrchloride
Brand Names
Salagen, Qlosi, VUITY
Hydrchloride
Brand Names
Salagen, Qlosi, VUITY
Form: Tablet, Solution
Method of administration: Oral, Ophthalmic
FDA approval date: February 21, 1996
Classification: Cholinergic Receptor Agonist
Pilocarpine hydrochloride tablets, USP are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with Sjogren's syndrome.
Bimatoprost
Brand Names
Lumigan, Latisse, Durysta
Bimatoprost
Brand Names
Lumigan, Latisse, Durysta
Form: Implant, Solution
Method of administration: Intracameral, Ophthalmic
FDA approval date: January 26, 2009
Classification: Prostaglandin Analog
LUMIGAN ® (bimatoprost ophthalmic solution)
Cosopt
Generic Name
Dorzolamide
Cosopt
Generic Name
Dorzolamide
Form: Solution
Method of administration: Ophthalmic
FDA approval date: October 28, 2008
Classification: Carbonic Anhydrase Inhibitor
Dorzolamide hydrochloride ophthalmic solution, USP is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Dorzolamide hydrochloride ophthalmic solution, USP is a carbonic anhydrase inhibitor indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Showing 1-5 of 16
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances